Medication-assisted treatment (MAT) is one of the most effective clinical tools available for addressing substance use disorders — and one of the most documentation-intensive. For behavioral health organizations running MAT programs, the stakes are high: incomplete or inconsistent records can mean denied claims, regulatory risk, and gaps in client care.
This guide walks through what MAT documentation requires, what to look for in a behavioral health Electronic Health Record (EHR), and where programs often run into trouble.
MAT is a whole-person approach to treating substance use disorders (SUD) that combines FDA-approved medications with counseling and behavioral therapies. It is primarily used to treat opioid use disorder (OUD) and alcohol use disorder (AUD).
The goal is not to substitute one substance for another. MAT works by normalizing brain chemistry, blocking the euphoric effects of opioids or alcohol, and relieving physiological cravings. It is evidence-based and associated with improved long-term recovery outcomes.
For opioid use disorder, the FDA has approved three core medications:
For alcohol use disorder, approved medications include:
MAT works best when pharmacologic therapy is integrated with other treatment options, such as counseling, group therapy, and peer recovery programs.
Poor documentation creates compliance risks and care gaps. MAT programs sit at the intersection of controlled substance prescribing, behavioral health documentation, and regulatory compliance. That combination makes thorough, accurate recordkeeping essential. Here is why it matters:
Effective MAT documentation spans the full treatment episode. Below are the core components every program needs to capture.
The intake process should capture a thorough substance use history, any prior treatment episodes, and a level-of-care determination. Screening tools such as SBIRT (Screening, Brief Intervention, and Referral to Treatment) support structured identification of disorder severity and co-occurring mental health conditions.
For buprenorphine, Electronic Prescribing of Controlled Substances (EPCS)-compliant prescriptions are required. Documentation should include the prescribed medication, dosage, any dose-titration notes, and, where applicable, the criteria used for take-home eligibility.
Programs need to document both UDS orders and the clinical interpretation of results. Simply recording a pass or fail is not sufficient. The record should reflect what the clinician did with the information and why.
Each encounter should capture client-reported symptoms, side effects, cravings, and treatment plan adherence. A Prescription Drug Monitoring Program (PDMP) query record should also be documented at each prescribing encounter.
Goals should be linked to measurable recovery milestones. Counseling attendance, group therapy participation, and progress toward those goals should be documented and updated regularly.
Not all EHR systems are built with SUD workflows in mind. General-purpose platforms often lack the structured forms, compliance controls, and integrations that MAT programs need. When evaluating a behavioral health EHR, look for these capabilities:
Look for an EHR designed specifically for behavioral health organizations that includes dedicated MAT Intake and MAT Follow-Up forms. These forms guide clinicians through structured documentation of medical history, substance use, withdrawal symptoms, and medication details — supporting both clinical quality and audit readiness.
Even experienced programs run into documentation gaps. The most common include:
MAT programs must satisfy multiple regulatory frameworks simultaneously, including SAMHSA certification standards, DEA controlled substance requirements, and 42 CFR Part 2 confidentiality rules. At minimum, documentation must cover the initial assessment and level-of-care determination, medication orders and titration history, UDS results with clinical interpretation, progress notes at each encounter, PDMP query records, treatment plan updates tied to measurable goals, and 42 CFR Part 2 consent forms.
Urine drug screen results should be documented with both the result and a clinician's interpretation of that result. Payers and auditors expect the record to show what clinical decision the result informed, not simply whether the screen was positive or negative. A behavioral health EHR should support ordering UDS tests, documenting results, and capturing the clinical rationale in a structured, reviewable format.
A MAT intake form captures foundational clinical information at the start of treatment: substance use history, prior treatment episodes, withdrawal symptoms, co-occurring conditions, and the initial medication order. A MAT follow-up form is used at subsequent encounters to document ongoing clinical status, including client-reported symptoms and cravings, side effects, PDMP query confirmation, UDS results, and treatment plan adherence. Both form types should be structured to support audit readiness and consistent clinical quality.
Accurate, complete MAT documentation is foundational to compliance, reimbursement, and quality care. When documentation is embedded into structured clinical workflows rather than left to free-text entries, programs are better positioned to meet regulatory requirements, support their behavioral health billing teams, and stay focused on what matters most: their clients' recovery.